Daewoong Pharmaceutical and Korea Health Screening Institution Council Sign MOU... Supply of Digital Healthcare Diagnostic Devices

"Actively Expanding Digital Health Screening Solutions
to the Clinic Screening Sector"

Daewoong Pharmaceutical has signed a Memorandum of Understanding (MOU) with the Korea Association of Health Screening Institutions (KAHSI) to supply the latest digital healthcare diagnostic devices to clinic-level medical institutions, thereby advancing health screening services.

Lee Chang-jae, CEO of Daewoong Pharmaceutical (right), and Kim Dong-il, Chairman of the Korea Health Screening Institutions Council, are posing for a commemorative photo after signing a business agreement at Daewoong Pharmaceutical headquarters in Gangnam-gu, Seoul on the 27th. Daewoong Pharmaceutical

According to Daewoong Pharmaceutical on the 31st, the signing ceremony took place on the 27th at Daewoong Pharmaceutical's headquarters in Gangnam-gu, Seoul, attended by Lee Chang-jae, CEO of Daewoong Pharmaceutical, and Kim Dong-il, chairman of KAHSI, among others.

Through this agreement, Daewoong Pharmaceutical and KAHSI will ▲ supply digital healthcare diagnostic devices to institutions affiliated with KAHSI ▲ provide expert consultation and verification for Daewoong Pharmaceutical’s new products ▲ closely cooperate in various fields including ESG activities and medical volunteer projects.

Daewoong Pharmaceutical will support premium precision screening at clinics by supplying the latest digital healthcare diagnostic devices such as the wearable electrocardiogram device 'MobiCare', ring-type continuous blood pressure monitor 'CartBP', AI-assisted diagnosis solution for blindness diseases 'Whiskey', fundus camera 'Optina Genesis', and continuous glucose monitor 'FreeStyle Libre' to KAHSI member institutions.

This agreement is particularly significant in terms of a 'paradigm shift in screening' through continuous digital measurement technology. In conventional health screenings, the reliability of test results such as blood pressure, blood glucose, and electrocardiograms was often compromised due to fasting, lack of sleep, and screening-related stress. For example, pre-colonoscopy dietary control sometimes caused fasting blood glucose to be measured lower than actual levels, or transient arrhythmias appeared during electrocardiogram tests.

The continuous digital measurement devices supplied by Daewoong Pharmaceutical overcome these limitations by collecting data under more routine and stable conditions, producing highly accurate results.

Additionally, Daewoong Pharmaceutical plans to collaborate with KAHSI-affiliated institutions to receive expert advice on new products and verify their effectiveness and usability in real-world settings. Through this, it is expected to develop highly reliable products and provide consumers with effective health solutions.

Medical volunteer projects aimed at addressing healthcare blind spots will also be actively promoted. Free health screenings and consultations will be provided to public institutions, local community residents, and workplace employees, thereby strengthening health management support for vulnerable groups. KAHSI will be responsible for planning volunteer programs and supporting medical personnel, while Daewoong Pharmaceutical will provide diagnostic devices, consumables, and hospital-use health functional foods.

Chairman Kim said, "This agreement is a meaningful attempt to elevate the reliability and convenience of health screenings to a new level," adding, "The limitations caused by temporary physiological changes and examinee stress in existing screening environments can now be overcome through continuous digital measurement technology."

CEO Lee stated, "Through this MOU, we will actively expand the latest digital health screening solutions, which were mainly used in university hospital screenings, to the clinic screening sector, and work closely with KAHSI so that more citizens can receive precise screenings more closely, quickly, and conveniently, thereby continuing healthy lives."

This content was produced with the assistance of AI translation services.